This company is about to flood the U.S. with cheap HIV drugs

Bloomberg

5 December 2017 - Patents on key branded medicines to start expiring soon.

Among the coconut plantations and beaches of South India, a factory the size of 35 football fields is preparing to churn out billions of generic pills for HIV patients and flood the U.S. market with the low-cost copycat medicines.

U.S. patents on key components for some important HIV therapies are poised to expire starting in December and Laurus Labs Ltd. -- the Hyderabad, India-based company which owns the facility -- is gearing up to cash in.

Read Bloomberg article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Pricing , Generic medicine